Status: Enrolling
Investigator: Mahendra Jain
Study Coordinator: Bela Jain
Phone: 281.485.3434
To determine the efficacy of CaPre 4 g daily, compared to placebo, in lowering fasting triglyceride levels in patients with fasting levels ≥500 mg/dL and ≤1500 mg/dL after 12 weeks of treatment. ... Read more >
Status: Enrolling
Investigator: Dipan Shah
Study Coordinator: Bevin Lopez
Phone: 713.441.6537
The American Diabetes Association estimates that 25.8 million individuals or 8.3% of the United States population have diabetes mellitus (DM). Individuals with diabetes have an increased risk for cardiovascular disease (CVD) and CVD events accou ... Read more >